NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.72M | 11.55M | 11.43M | 11.42M | 11.21M |
| Total Other Revenue | 759.20K | 563.80K | 459.70K | 421.20K | 447.60K |
| Total Revenue | 12.48M | 12.11M | 11.89M | 11.84M | 11.65M |
| Cost of Revenue | 2.17M | 2.28M | 2.31M | 2.26M | 2.46M |
| Gross Profit | 10.30M | 9.83M | 9.58M | 9.58M | 9.19M |
| SG&A Expenses | 8.00M | 7.84M | 7.77M | 7.78M | 7.90M |
| Depreciation & Amortization | 905.30K | 904.90K | 907.00K | 924.70K | 933.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.07M | 11.03M | 10.99M | 10.97M | 11.30M |
| Operating Income | 1.40M | 1.08M | 900.40K | 873.00K | 355.20K |
| Income Before Tax | 1.33M | 1.01M | 774.40K | 747.90K | 208.40K |
| Income Tax Expenses | 294.40K | 294.20K | 294.00K | 292.90K | 18.60K |
| Earnings from Continuing Operations | 1.03 | 0.71 | 0.48 | 0.45 | 0.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.03M | 712.50K | 480.30K | 454.90K | 189.70K |
| EBIT | 1.40M | 1.08M | 900.40K | 873.00K | 355.20K |
| EBITDA | 2.10M | 1.78M | 1.60M | 1.61M | 1.28M |
| EPS Basic | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 283.82M | 283.78M | 283.59M | 283.39M | 283.46M |
| Average Diluted Shares Outstanding | 308.35M | 295.18M | 295.18M | 291.19M | 291.25M |
| Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 63.88% | 56.27% | 83.97% | 88.99% | 337.22% |